paul ebeling on macy's, inc. (m), pfizer inc. (pfe), potash corporation of saskatchewan...

16
The Red Roadmaster’s US Market Monthly Re-cap + Stock Talk ™ 14 March 2010 Date Line: Bangkok, Thailand You can now follow us on Twitter please go to http://twitter.com/EbelingHefferna and join in. Red’s Bull Alert: The Major Indexes closed higher for the 2 nd week running and turned Bullish from Neutral. Re-cap of the US Stock Market Action for the Week ending 12 March 2010 Wall Street closed flat on Friday On the Day: The DJIA added 12.85 pts, or 0.12%, to close at 10,624.69, the S&P 500 lost ¼ pt, or 0.02%, to close at 1,149.99, and the NAS tallied up a minus 0.80 pt, or 0.03% to end the session at 2,367.66. On the Week: The Major Indexes closed higher for the 2 nd week running, the DJIA gained 0.55%, the S&P 500 added 1% and the leading NAS posted a + 1.78% The S&P 500 was not able to build on Thursday's gainer that pushed it to a 17 month high. February retail sales rose after forecasts had called for a decline and a DJ index of retailer stocks gained 0.5 %. Macy's Inc rose 3.3% to US$21.75/shr. 1

Upload: shayne-heffernan

Post on 10-Mar-2016

220 views

Category:

Documents


2 download

DESCRIPTION

Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT), and United Technologies Corporation (UTX)

TRANSCRIPT

Page 1: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

The Red Roadmaster’s US Market Monthly Re-cap + Stock Talk ™

14 March 2010 Date Line: Bangkok, Thailand

You can now follow us on Twitter please go to http://twitter.com/EbelingHefferna and join in.

Red’s Bull Alert: The Major Indexes closed higher for the 2nd week running and turned Bullish from Neutral.

Re-cap of the US Stock Market Action for the Week ending 12 March 2010

Wall Street closed flat on Friday

On the Day: The DJIA added 12.85 pts, or 0.12%, to close at 10,624.69, the S&P 500 lost ¼ pt, or 0.02%, to close at 1,149.99, and the NAS tallied up a minus 0.80 pt, or 0.03% to end the session at 2,367.66.

On the Week: The Major Indexes closed higher for the 2nd week running, the DJIA gained 0.55%, the S&P 500 added 1% and the leading NAS posted a + 1.78%

The S&P 500 was not able to build on Thursday's gainer that pushed it to a 17 month high.

February retail sales rose after forecasts had called for a decline and a DJ index of retailer stocks gained 0.5 %. Macy's Inc rose 3.3% to US$21.75/shr.

US Bank shares lost some momentum after dominated the week's action: Citigroup Inc. fell 5% to US$3.97/shr on Friday, but was up 13.4% on the week, its best showing since last August. Friday, the KBW bank index .BKX dropped 0.9%.

Health insurers' stocks fell as a group, with the Morgan Stanley healthcare payor index .HMO down 1.4%, its largest daily percentage drop in 3 weeks.

Caterpillar Inc added 2.5% to US$60.36/shr and was the DJIA’s top points gainer a day after the heavy equipment maker said it could triple its current US output of hydraulic excavators.

The US Commerce Department said business inventories were unchanged in January, against a forecast for a 0.2% rise.

1

Page 2: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

Commodities saw mixed interest session Friday as the CRB Commodity Index finished flat. However, Crude Oil prices fell 1.1% to US$81.24 bbl. Crude Oil prices had topped US$83 bbl in the early going as news circulated that the International Energy Agency (IEA) expects Crude Oil demand to rise this year.

The flat finish among both commodities and stocks marked quiet close to the week's trade, though action in previous sessions combined for a considerable weekly move. The CRB Commodity Index fell 1.3% on the week, and stocks closed with a 1.0% gain on the week.

Advancing Sectors: Industrials (+0.7%), Materials (+0.6%), Consumer Discretionary (+0.2%), Tech (+0.1%)

Declining Sectors: Utilities (-0.7%), Financials (-0.4%), Health Care (-0.4%); Telecom (-0.2%), Energy (-0.1%)

Unchanged: Consumer Staples

Volume and Breadth: about 8.3B/shrs traded on the NYSE, the AMEX and NAS, below last year's estimated daily average of 9.65 b/shrs. Advancers outnumbered decliners on the NYSE by about 5 to 4, and on the NAS about 6 stocks fell for each 5 that rose.

Red on Crude Oil and Gold...

Nymex Crude Oil (CL)

The Northside moment is slowing in Crude Oil, but a continued rise is likely with 80.16 the minor support in here.

The current rally from 69.50 looks to extend for a retest the 83.95 high. But a break of 80.16 will indicate that a short term top is in place now, and deeper pull back should be seen to 38.2% retracement of 69.50 to 83.03 at 77.86 and below.

The Big Picture: Crude Oil was supported above 68.59 the Key support level, and so there was no confirmation of medium term reversal. The strong rebound from 69.50 dampened my Bearish POV, and augurs that the medium term rise from 33.2 may not be over yet.

But as such rise from 33.2 is treated as a correction to the whole decline from 147.27 only, even in case of another high above 83.95, I do continue to expect strong resistance near to 50% retracement of 147.27 to 33.2 at 90.24 to bring a reversal.

On the Downside: a break of the 69.50 support would indicate that Crude Oil has topped out in medium term and will turn the outlook Bearish. Stay tuned…

Comex Gold (GC)

Gold recovered after dipping to 1100.5 but the correction from 1145.8 might still continue in here. But any downside should be contained at the 1088.5 support level, and bring a Rally resumption. A close above 1128.3 will flip intra-day bias back to the Northside. And a further break of 1145.8 will then target

2

Page 3: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

the resistance at1163 next. But a sustained break of 1088.5 will indicate that entire rise from 1044.5 is completed and will turn outlook Bearish for another move towards this low.

The Big Picture: the price action from 1227.5 is treated as correction to rise from 931.3 only and might have completed at 1044.5 already after being supported by 61.8% retracement of 931.3 to 1227.5 at 1044.4. A strong break of the 1163 resistance will confirm this action. On a Rally resumption, the next medium term target will be 100% projection of 931.3 to 1227.5 from 1044.5 at 1340.7.

On the Downside: a break of the 1088.5 Key support will in then augur that correction from 1227.5 would extend further before completion. Stay tuned….

Market Indexes Technical Analysis

Date Symbol Price Technical Analysis Support Resistance

Mar-12-2010 QQQQ 47.36 Bullish (0.42) 46.92 48.69

Mar-12-2010 DIA 106.42 Bullish (0.28) 105.88 107.17

Mar-12-2010 SPY 115.46 Bullish (0.27)102.02

Stocks to Watch Today

Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT), and United Technologies Corporation (UTX)

Macy's, Inc. (M) Up-date 5 Last Look: February 24, 2010

3

Page 4: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

March 14, 2010

Paul A. Ebeling, Jnr. Analyst

Today, let’s look at Macy's, Inc. (M), the giant # 1 USA department store operator, from a Technical POV. The overall indications, after Friday’s (March 12) market action, are Bullish: in the near term, , Bullish mid-term Bullish, and long term Bullish. The recent Candle Stick analysis is: Bullish

**Chart by: http://www.stockta.com

Latest News and Opinion: Consumer Spending Perks Up US Economy

http://online.wsj.com/article/SB10001424052748703447104575117942059388092.html?ru=yahoo&mod=yahoo_hs

Friday’s Market Action Close 21.75 + .69 Volume 13,393,700/shrs

4

Page 5: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

There is a Bullish Engulfing Candle on March 10 and no Gaps open up or down on the Chart, the near term resistance is 21.93, support at 20.91, and the 50 day (EMA) exponential moving average is 18.39.

This is Macy's, Inc. (M): Macy’s is the USA’s #1 department store chain has adopted the name of its most famous brand and cash cow: Macy's. Macy's, Inc. (formerly Federated Department Stores) operates 840-plus stores in 45 states and rings up more than $26 billion in annual sales. The name change comes on the heels of its acquisition of rival May Department Stores in 2005. The retail giant operates four regional divisions: Macy's East, Macy's Central, Macy's Florida, and Macy's West, and the upscale Bloomingdale's chain. The department stores sell men's, women's, and children's apparel and accessories, cosmetics, and home furnishings (including the Martha Stewart Collection), among other things. Macy's began as a dry goods store 150 years ago.

Industries Where Macy's Competes

Retail

Department Stores (primary)Apparel & Accessories RetailCosmetics, Beauty Supply & Perfume RetailNonstore RetailCatalog, Mail Order & Television Sales

Macy's, Inc. (HQ)

Chairman, Chief Exec. Officer, President, Terry J. Lundgren

7 West 7th StreetCincinnati, OH 45202United States Phone: 513-579-7000Fax: 513-579-7555

http://www.macysinc.com

Macy's Subsidiaries Bloomingdale's, Inc.Macy's CentralMacy's East

Pfizer Inc. (PFE) Up-date 6 Last Look: December 10, 2009

5

Page 6: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

March 14, 2010

Paul A. Ebeling, Jnr. Analyst

Let’s have a look at Pfizer Inc. (PFE), the Giant manufacturer of prescription medicines for humans and animals worldwide, from a Technical POV. The overall indications, after Friday’s (March 12) market action is Bearish: in the near term Bearish, mid-term Bearish, and long term Bearish. The recent Candle Stick Analysis is: Very Bullish.

**Chart by: http://www.stockta.com

Latest News and Opinion: Cancer Drugs May Not Cure Pfizer

http://blogs.forbes.com/sciencebiz/2010/03/cancer-drugs-may-not-cure-pfizer/?partner=yahootix

Friday’s Market Action Close 17.08 -.21 Volume 85,428,500/shrs

6

Page 7: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

There is a Bullish engulfing Candle on March 11 and one Gap open up on November 9, 2009 at 17.02/17.03 the near term resistance is 17.23, support at 17.02 and the 50 day (EMA) exponential moving average is 17.93.

This is Pfizer Inc. (PFE): The Company engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer’s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company’s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. Pfizer, Inc. was founded in 1849 and is headquartered in New York, New York.

Competitive Landscape

The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is dominated by the large manufacturers/marketers that manufacture drugs, have large research operations, and also have large clinical testing, marketing, and distribution capabilities. Small companies are mainly research operations or manufacturers of non-prescription products. Because of the high value of the product, average revenue per employee is a very high US$600,000.

Pharmaceutical Manufacture and Sale Industry Forecast

The output of US drug manufacturing is forecast to grow at an annual compounded rate of 8 % between 2008 and 2013. Data Sourced: December 2009

Pfizer Inc. (HQ)Chairman, Chief Exec. Officer Jeffrey B. Kindler 235 East 42nd StreetNew York, NY 10017United States Phone: 212-573-2323Fax: 212-573-7851

http://www.pfizer.com

Pfizer Subsidiaries

Pfizer Health Solutions IncPfizer Ireland PharmaceuticalsPfizer Limited

7

Page 8: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

Potash Corp of Saskatchewan Inc (POT) Up-date 4 Last Look: January 25, 2010

March 14, 2010

Paul A. Ebeling, Jnr. Analyst

Today, let’s have a look at Potash Corporation of Saskatchewan Inc.(POT), the world leader in the production of potash fertilizer, from a Technical POV. The overall indications, after Friday’s (March 12) market action, are Bullish: in the near term Bullish, mid-term Bullish, and long term Neutral. The recent Candle Stick analysis is: Neutral

**Chart by: http://www.stockta.com

Latest News and Opinion: Potash Boosts Guidance on Rising Demand

http://www.investors.com/NewsAndAnalysis/Article.aspx?id=527198

8

Page 9: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

Friday’s Market Action Close 125.77 + 8.34 Volume 17,348,400/shrs

There is a Hammer on March 8, and one Gap open up on March 12 at 117.96/123.10, the near term resistance is 125.98, support at 124.04, and the 50 day exponential moving average is 112.73.

This is Potash Corp: Potash Corp, is the world's leading producer of potash fertilizer. The company also produces nitrogen used in fertilizer plus many industrial and consumer products, and phosphate for feed products, food products, and detergents. Its annual production capacity of 10MM tons of potash accounts for more than 20% of the world's capacity. Potash Corp also sells these minerals as phosphate feed ingredients for animal nutrition and as nitrogen products for the industrial chemicals market. The company has 20 plants in North America, Brazil, Chile, and Trinidad.

Competitive Landscape

Demand for agricultural chemicals depends mainly on demand for various crops, which in turn depends on crop prices. The profitability of individual companies is linked to efficient operations and marketing. Big producers have large economies of scale in production. Smaller companies can compete effectively by making specialty chemicals or fertilizer mixtures for local markets. Operations are capital-intensive and highly automated: annual revenue per employee at a large plant is close to US$700,000.

Chemical Manufacturing - Agricultural Industry ForecastThe output of US agricultural fertilizers and chemicals is forecast to grow at an annual compounded rate of 4.2% between 2008 and 2013.

Potash Corporation (HQ) President, CEO & Director William J. (Bill) Doyle

500-122 1st Ave. SouthSaskatoon, Saskatchewan S7K 7G3, Canada Phone: 306-933-8500Fax: 306-933-8844Toll Free: 800-667-3930

http://www.potashcorp.com

Potash Corp Subsidiaries Canpotex Limited PCS Nitrogen, Inc. PCS Phosphate Company, Inc.

9

Page 10: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

United Technologies Corporation (UTX) Up-date 3 Last Look: June 8, 2009

March 14, 2010

Paul A. Ebeling, Jnr. Analyst

Today, let’s look at United Technologies Corporation (UTX), the huge US big brand conglomerate, from a Technical POV. The overall analysis after Friday’s (June 5, 2009) market action is Neutral: in the near term Neutral, mid-term Bullish, and long term Neutral. The recent Candle Stick analysis is: Very Bearish

**Chart by: http://www.stockta.com

Latest News and Opinion: United Tech sees double-digit Y 2010 profit growth

http://www.reuters.com/article/idCNN1212341220100312?rpc=44

10

Page 11: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

Friday’s Market Action Close 71.53 -.51 Volume 5,805,500/shrs

There is a Hammer on March 11 and two Gaps open up on October 6 and November 4, 2009 at 60.48/63.39, the near term resistance is 72.83, support at 71.46, and the 50 day (EMA) exponential moving average is 69.09.

This is United Technologies Corporation (UTX): United Technologies lifts you up and cools you off with it portfolio of well know brands: Carrier, Otis, Pratt & Whitney, and Sikorsky. UTC makes building systems and aerospace products. Carrier is the world's largest maker of heating and air-conditioning units. Otis is the #1 elevator manufacturer; Hamilton Sundstrand produces engine controls, environmental systems, propellers, and other flight systems; Pratt & Whitney makes engines for both commercial and military aircraft; and Sikorsky makes helicopters. The UTC Fire & Security segment is made up of what were Chubb and Kidde plus UTC Power makes fuel cells for commercial, transportation, and space applications, among other products.

The Competitive Landscape

Demand is driven by the US military budget and the overall economic climate, which affects airline traffic and demand for new commercial aircraft. The profitability of individual companies depends on technical expertise and the ability to accurately price long-term contracts. Large companies enjoy economies of scale in design, manufacturing, and purchasing. Small companies can compete effectively by concentrating on selected components and parts manufacturing for particular prime contractors. Increasingly, small companies are developing system integration capabilities as large firms outsource more aspects of contracts. Production of aircraft and major aircraft components is highly automated: average revenue per employee is over US$300,000.

Aerospace Products and Parts Manufacture Industry ForecastThe output of US aerospace products is forecast to grow at an annual compounded rate of 6.8 % between 2008 and 2013.

United Technologies Corporation (HQ)

Chairman George David

President, CEO, and Director Louis R. Chênevert

1 Financial PlazaHartford, CT 06103United States  Phone: 860-728-7000Fax: 860-565-5400

http://www.utc.com

United Technologies SubsidiariesCarrier CorporationForney CorporationHamilton Sundstrand Corporation

Disclaimer

11

Page 12: Paul Ebeling on Macy's, Inc. (M), Pfizer Inc. (PFE), Potash Corporation of Saskatchewan Inc.(POT)

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN OUR NEWSLETTERS. Red Roadmaster is not registered as a securities broker-dealer or an investment advisor either within the US Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies’ profiled based solely on information contained in our report. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stock broker before investing.

Information contained in the Redroadmaster Stock Talk report will contain “forward looking statements” as defined under section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

Red Roadmaster is committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

 To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in this report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org

12